Interventional study for severe obesity patients with non-alcoholic fatty liver disease (NAFLD) by Mazindol
Not Applicable
- Conditions
- Severe obesity patient with non-alcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000022879
- Lead Sponsor
- Gunma University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Allergy to Mazindol, Glaucoma, Severe heart disease, Severe diabetes mellitus, Severe liver and renal disturbance, Severe hypertension, Cerebrovascular disease, Mental illness, Seizure, Alcohol and drug abuse, MAO inhibitor, Pregnant woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in body weight 12 weeks after administration
- Secondary Outcome Measures
Name Time Method Improvement in liver function 12 weeks after administration